General Information of the Compound
| Compound ID |
CP0001250
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene
Show/Hide
|
||||||||||||||||||
| Synonyms |
1204918-72-8
4029AH
40D08182TT
937270-47-8
AKOS030527020
AKOS032950000
AOB87361
BCP07033
BDBM50363196
C23H24N4O
CHEMBL1944698
CS-0884
EX-A239
GTPL9095
HY-15166
KB-80503
MolPort-039-139-793
SB-1317
SB-1317 free base
SB1317
SB1317(TG-02)
SB14606
SCHEMBL17595943
SCHEMBL2298965
SCHEMBL823947
TG-02
TG02
TG02 (Double bond E)
TG02 (Double bond Z/E)
TG02 [WHO-DD]
Tube011
UNII-40D08182TT
W-5884
ZINC68251500
compound 26h [PMID: 22148278]
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H24N4O
|
||||||||||||||||||
| Molecular Weight |
372.472
|
||||||||||||||||||
| Canonical SMILES |
CN1C\C=C\CCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+
Show/Hide
|
||||||||||||||||||
| InChIKey |
VXBAJLGYBMTJCY-NSCUHMNNSA-N
|
||||||||||||||||||
| CAS |
937270-47-8
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound